Browsing: combination
Preoperative treatment with the new drug vidutolimod and the PD-1 checkpoint inhibitor nivolumab led to tumor control in 55% of…
A new tool for tracking patterns of immune health over time has revealed how a pair of checkpoint inhibitor therapies…
The combination of the antibody amivantamab and lazertinib, a drug that targets EGFR, shows better clinical benefits compared with standard…
Originally published in May 2021. I have always faced a challenge to find the best face wash for my combination…
The PrE0405 phase 2 trial met its primary endpoint, achieving a complete response (CR) rate of 85% in 33 patients…
The combination of the JAK inhibitor ruxolitinib with the BCL-xL inhibitor navitoclax was twice as effective in reducing spleen enlargement…